These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
722 related items for PubMed ID: 16005254
1. HIV chemokine receptor inhibitors as novel anti-HIV drugs. Princen K, Schols D. Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254 [Abstract] [Full Text] [Related]
2. HIV co-receptors as targets for antiviral therapy. Schols D. Curr Top Med Chem; 2004 Dec; 4(9):883-93. PubMed ID: 15134547 [Abstract] [Full Text] [Related]
3. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4. Boutet A, Salim H, Taoufik Y, Lledo PM, Vincent JD, Delfraissy JF, Tardieu M. Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179 [Abstract] [Full Text] [Related]
4. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. De Clercq E, Schols D. Antivir Chem Chemother; 2001 May; 12 Suppl 1():19-31. PubMed ID: 11594685 [Abstract] [Full Text] [Related]
5. What's New in HIV/AIDS? Chemokine receptor antagonists: a new era of HIV therapy? Jülg B, Goebel FD. Infection; 2005 Oct; 33(5-6):408-10. PubMed ID: 16258879 [Abstract] [Full Text] [Related]
8. Pouncing on the chemokine receptor Chimera. Mascolini M. J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):13-24. PubMed ID: 11364629 [Abstract] [Full Text] [Related]
10. Genotypic coreceptor analysis. Sierra S, Kaiser R, Thielen A, Lengauer T. Eur J Med Res; 2007 Oct 15; 12(9):453-62. PubMed ID: 17933727 [Abstract] [Full Text] [Related]
11. Prospects of HIV-1 entry inhibitors as novel therapeutics. Pierson TC, Doms RW, Pöhlmann S. Rev Med Virol; 2004 Oct 15; 14(4):255-70. PubMed ID: 15248253 [Abstract] [Full Text] [Related]
12. The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies. Dhami H, Fritz CE, Gankin B, Pak SH, Yi W, Seya MJ, Raffa RB, Nagar S. J Clin Pharm Ther; 2009 Apr 15; 34(2):147-60. PubMed ID: 19250135 [Abstract] [Full Text] [Related]
13. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications]. Azevedo-Pereira JM, Santos-Costa Q. Acta Med Port; 2008 Apr 15; 21(5):497-504. PubMed ID: 19187693 [Abstract] [Full Text] [Related]
15. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals. Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF. AIDS; 2008 Jul 31; 22(12):1425-31. PubMed ID: 18614865 [Abstract] [Full Text] [Related]
16. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics. Suresh P, Wanchu A. J Postgrad Med; 2006 Jul 31; 52(3):210-7. PubMed ID: 16855325 [Abstract] [Full Text] [Related]
17. CCR5 antagonists: a new tool in fighting HIV. Jülg B, Goebel FD. J HIV Ther; 2005 Dec 31; 10(4):68-71. PubMed ID: 16519245 [Abstract] [Full Text] [Related]
18. Roles of chemokines and chemokine receptors in HIV-1 infection. Murakami T, Yamamoto N. Int J Hematol; 2000 Dec 31; 72(4):412-7. PubMed ID: 11197206 [Abstract] [Full Text] [Related]
19. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density. Willey S, Peters PJ, Sullivan WM, Dorr P, Perros M, Clapham PR. Antiviral Res; 2005 Nov 31; 68(2):96-108. PubMed ID: 16157392 [Abstract] [Full Text] [Related]